Evidence map›Paper›PMID 42911393›Full record

ArticleAbdominal radiology (New York)2026

An interpretable contrast-enhanced CT-based cross-attention transformer model for predicting progression-free survival in muscle-invasive bladder cancer: a multicenter study.

Yuanyuan Liu, Zhe Xu, Jun Xia, Li Guo, Wenyu Hou, Bing Qu, Yonghua Huang, Shifeng Yang, Suyun Li, Zaixian Zhang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuanyuan LiuAffiliated Hospital of Qingdao University, Qingdao, China.ORCID https://orcid.org/0009-0006-1263-9487
Zhe XuAffiliated Hospital of Qingdao University, Qingdao, China.
Jun XiaAffiliated Hospital of Qingdao University, Qingdao, China.
Li GuoQingdao University, Qingdao, China.
Wenyu HouQingdao University, Qingdao, China.
Bing QuQingdao University, Qingdao, China.
Yonghua HuangThe Puyang Oilfield General Hospital, Puyang, China.
Shifeng YangShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Suyun LiGuangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong, China.
Zaixian ZhangAffiliated Hospital of Qingdao University, Qingdao, China. zhangzx7305@qdu.edu.cn.
Hexiang WangAffiliated Hospital of Qingdao University, Qingdao, China. wanghexiang@qdu.edu.cn.ORCID https://orcid.org/0000-0001-8313-7632

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with muscle-invasive bladder cancer (MIBC) typically have a dismal prognosis, even after undergoing radical cystectomy (RC). To address this limitation, we constructed and evaluated a preoperative deep learning (DL) model that leverages computed tomography (CT) imaging to stratify MIBC patients according to their risk of postoperative disease progression.

methodsData from MIBC patients undergoing RC at one of four institutions were retrospectively analyzed and allocated to training and validation cohorts. A dual-channel information fusion DL model was developed to predict the postoperative risk of progression according to preoperative CT images. Subsequently, a DL-based clinical signature was created by combining clinical features with the DL-derived score. The concordance index (C-index) and area under the curve (AUC) were used to evaluate the DL model's predictive capability, which was compared with the DL-based clinical signature, a clinical model, and a Ki67 model.

resultsIn the retrospective cohort of 427 patients with MIBC, the DL score demonstrated favorable predictive performance for disease progression in the validation cohort (C-index: 0.774; AUC: 0.785), and generally showed higher predictive performance than the comparator models in the validation cohort. Using an optimal threshold, the patient cohort was categorized into two distinct subgroups, high-risk and low-risk, with differences in the cumulative incidence of progression observed between the two groups, supporting the model's ability to stratify patients according to progression risk.

conclusionsThe utilization of preoperative CT imaging in a DL framework enabled PFS prediction and risk stratification in patients with MIBC, with potential value for individualized postoperative surveillance.

Indexed as

Contrast-enhanced CTCross-attentionMuscle-invasive bladder cancerSHAPTransformer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.